Regeneron Pharmaceuticals (REGN) Operating Income (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded Operating Income of $1.29 billion in Q2 2026, up 19.8% from $1.08 billion a year earlier and up 101.2% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Operating Income (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' Operating Income came in at $3.84 billion as of Jun 30, 2026, up 0.1% year-over-year; for FY2025, it came in at $3.58 billion, down 10.3% from FY2024.
- Annual Operating Income has declined for four straight years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- Across earlier years, Operating Income came in at $3.99 billion in FY2024 (-1.4%), $4.05 billion in FY2023 (-14.6%), $4.74 billion in FY2022 (-47.0%) and $8.95 billion in FY2021 (+150.1%).
- The Q2 2026 figure is the highest quarterly Operating Income since Q4 2021.
- On a year-over-year basis, Operating Income rose in five of the last eight quarters, with an average decline of 1.0%.
- Peak year-over-year performance for Operating Income in the last five years was growth of 126.2% in Q4 2021, against a decline of 66.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $642.9 million (Q1 2026), $879.9 million (Q4 2025) and $1.03 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 642.90 Mn |
| Dec 31, 2025 | 879.90 Mn |
| Sep 30, 2025 | 1.03 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 591.70 Mn |
| Dec 31, 2024 | 990.20 Mn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 751.40 Mn |
| Dec 31, 2023 | 972.90 Mn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 946.70 Mn |
| Dec 31, 2022 | 1.15 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 2.64 Bn |
| Sep 30, 2021 | 1.85 Bn |
API Access
Regeneron Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();